Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-19-001986

EVP & Chief Financial Officer sold 6,061 shares at an average $26.37 ($159,811)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kelly James Patrick EVP & Chief Financial Officer 2019-01-02 Sale −3,313 $26.31 $87,165 196,221 D: show line 1 in the form
Kelly James Patrick EVP & Chief Financial Officer 2019-01-02 Sale −1,129 $26.94 $30,414 195,092 D: show line 2 in the form
Kelly James Patrick EVP & Chief Financial Officer 2019-01-03 Sale −1,619 $26.09 $42,232 193,473 D: show line 3 in the form
Open-market sales · 6,061 sh · avg $26.37 · $159,811
Loading xslF345X03/doc4.xml…